|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM283134348 |
003 |
DE-627 |
005 |
20231225035741.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2018 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.201705605
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0943.xml
|
035 |
|
|
|a (DE-627)NLM283134348
|
035 |
|
|
|a (NLM)29665153
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Lin, Yu-Jung
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a In Situ Self-Assembling Micellar Depots that Can Actively Trap and Passively Release NO with Long-Lasting Activity to Reverse Osteoporosis
|
264 |
|
1 |
|c 2018
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.03.2019
|
500 |
|
|
|a Date Revised 30.09.2020
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
520 |
|
|
|a Treatment with exogenous nitric oxide (NO) donors is regarded as being effective against osteoporosis. However, NO has a short half-life, limiting its clinical usefulness. To overcome this limitation, an injectable microparticle (MP) system is developed that consists of phase-change materials capric acid (CA) and octadecane, and encapsulates a NO donor. The therapeutic efficacy of the MPs is evaluated in ovariectomized (OVX) rats with osteoporosis. Upon subcutaneous administration, the MPs undergo a phase transition, leaching out the NO donor and generating NO bubbles that are instantly covered by a layer of tightly packed CA surfactant molecules, forming micellar depots. The in situ self-assembling micellar depots can actively protect the NO bubbles, prolonging their half-life, while the entrapped NO may passively diffuse through the micellar depots over time, performing a long-lasting therapeutic function, reversing the OVX-induced osteoporosis. It is possible to use the concept of in situ self-assembling micellar depots developed herein to expand the therapeutic effect of NO in its diverse range of clinical applications
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a bubble generation
|
650 |
|
4 |
|a capric acid
|
650 |
|
4 |
|a micellar depot
|
650 |
|
4 |
|a nitric oxide
|
650 |
|
4 |
|a osteoporosis
|
650 |
|
7 |
|a Micelles
|2 NLM
|
650 |
|
7 |
|a Nitric Oxide
|2 NLM
|
650 |
|
7 |
|a 31C4KY9ESH
|2 NLM
|
700 |
1 |
|
|a Chen, Chun-Chieh
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chi, Nai-Wen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nguyen, Trang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lu, Hung-Yun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nguyen, Dang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Lai, Po-Liang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sung, Hsing-Wen
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 30(2018), 22 vom: 17. Mai, Seite e1705605
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:30
|g year:2018
|g number:22
|g day:17
|g month:05
|g pages:e1705605
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201705605
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 30
|j 2018
|e 22
|b 17
|c 05
|h e1705605
|